Abstract
Following its discovery by Durand, et al., (1966), fucosidosis has been defined as a grave disease of infancy and early childhood with premature death. This concept had to be modified when Patel, et al., (1972) observed hitherto unknown aspects of this enzyme defect, namely the occurrence of angiokeratoma corporis diffusum and extension of the lifespan into adulthood. Nevertheless, their patient also had severe mental retardation, was dwarfed, and exhibited gargoylian features.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
BAHL, O. P.: Glycosidases of Aspergillus Niger, II Purification and general properties of 1,2,-α-L-fucosidase. J. Biol. Chem., 245: 299 (1970).
BECK, C., MAHADEVAN, S., BRIGHTWELL, R., DILLARD, C., and TAPPEL, A. L.: Chromatography of lysosomal enzymes. Arch. Biochem. Biophys., 128: 369 (1968).
BRUNNGRABER, E. G., BROWN, B. D., and HOF, H.: Determination of gangliosides, glycoproteins and glycosamine. Clin. Chem. Acta, 32: 159 (1971).
DISCHE, Z., and SHETTLES, L. B.: A specific color reaction of methylpentoses and a spec-rophotometric micromethod for their determination. J. Biol. Chem., 175: 595 (1948).
DURAND, P., BORRONE, C., and DELLA CELLA, G.: A new mucopolysaccharide lipid storage disease? Lancet 2: 1313 (1966).
GATTI, R., BORRONE, C., TRIAS, X., and DURAND, P.: Genetic heterogeneity in fucosidosis. Lancet 2: 1024 (1973).
HOOGWINKEL, J., VELTKAMP, W., OVERDIJK, R., and LISMAN, J.: Electrophoretic separation of β-N-acetylhexosaminidases of human and bovine brain and liver and of Tay-Sachs brain tissue. Hoppe-Seyler’s Z. Physiol. Chem. 353: 839 (1972).
KOSCIELAK, J.: Blood group A specific glycolipids from human erythrocytes. Biochim. Biophysic. Acta 78: 313 (1963).
KOUSSEFF, B., BERATIS, N., DANESINO, C., and HIRSCHHORN, K.: Genetic heterogeneity in fucosidosis. Lancet 2 1387 (1973).
LUNDBLAD, A.: An ultrafilterable non-dialyzable fucose-rich glycopeptide fraction in normal human urine. Biochim. Biophys. Acta 101: 177 (1965).
MACPHEE, G., LOGAN, R., and PRIMROSE, D.: Fucosidosis: How many cases undetected? Lancet 2: 462 (1975).
PATEL, V., and TAPPEL, A.L.: Lysosomal β-galactosidoses of rat kidney. Biochim. Biophys. Acta 220: 622 (1970).
PATEL, V., WATANABE, I., and ZEMAN, W.: Deficiency of α-fucosidase. Science 176: 426 (1972).
PRIMROSE, D.: Mucopolysaccharidosis: A new variant? J. Ment. Defic. Res. 16: 167 (1971).
ROBINSON, B. and THORPE, R.: Fluorescent assay of crfucosidase. Clin. Chim. Acta 55: 65 (1974).
SNYDER, R. and BRADY, R.: The use of white cells as a source of diagnostic material for lipid storage diseases. Clin. Chim. Acta 25: 331 (1969).
SUZUKI, Y., BERMAN, P., and SUZUKI, K.: Detection of Tay-Sachs disease heterozygote by assay of hexosaminidase A in serum and leukocytes. J. Pediat. 78: 634 (1971).
VAN HOOP, P.: Fucosidosis. in “Lysosomes and storage diseases”. (H.G. HERS and P. VAN HOOP, Eds.). Academic Press, p. 277 (1973).
WIEDERSCHAIN, G.Y. and ROSENFELD, E.L.: Two forms of α-L-fucosidase from pig kidney and their action on natural oligosaccharides. Biochem. Biophys. Res. Comm. 44.: 1008 (1971).
WIEDERSCHAIN, G., KOLIBABA, L., and ROSENFELD, E.: Human α-L-fucosidases. Clin. Chim. Acta 46: 305 (1973).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1976 Plenum Press, New York
About this chapter
Cite this chapter
Patel, V., Zeman, W. (1976). Variability of Expressivity of α-Fucosidase Deficiency. In: Volk, B.W., Schneck, L. (eds) Current Trends in Sphingolipidoses and Allied Disorders. Advances in Experimental Medicine and Biology, vol 68. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-7735-1_11
Download citation
DOI: https://doi.org/10.1007/978-1-4684-7735-1_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-7737-5
Online ISBN: 978-1-4684-7735-1
eBook Packages: Springer Book Archive